Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride.
A controlled double-blind trial is reported of the parasympatholytic drug, flavoxate hydrochloride, and the new sympathomimetic drug, clenbuterol, in the treatment of 39 women with motor urge incontinence. The clinical results and the urodynamic findings of urethro-cystomanometry after therapy showed clenbuterol to be very effective with few side effects.
D002976:Clenbuterol / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D005422:Flavoxate / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D014549:Urinary Incontinence / Q000188:drug therapy* / Q000503:physiopathology; D014551:Urinary Tract / Q000503:physiopathology; D014563:Urodynamics
D004983:Ethanolamines; D005419:Flavonoids; D005422:Flavoxate; D002976:Clenbuterol